Circassia

Fountain Medical Development is a clinical contract research organization (CRO) offering a full range of ICH GCP compliant clinical research services in China, US, Japan, and Europe. FMD has extensive global experience in multiple therapeutic areas. The company has completed dozens of registrations trials which supported marketing authorization applications in US and Europe.

Our people is the basis of our success. The 1,700+ professionals are dedicated and diverse. At any given moment, at least 3 languages are spoken in our 20 offices in Asia, US, and Europe.

FMD is on the forefront of the paradigm shift in global clinical development. The regulatory reform in China has the potential to fundamentally change how an innovative therapy is developed. FMD is on the frontline building and shaping the future.

FMD is large enough to serve 7 out the 10 largest Pharma companies, and nimble enough to customize to the needs of startup firms.

In the US and Europe, FMD is doing business as FMD K&L. In China, we operate under the name FMD. Whatever the names are, the company is managed globally by a seasoned senior management team comprised of industry veterans.

Together we build a bright future.

Pharma Medica Research is a full service early phase contract research organization. We offer an innovative approach to the design and implementation of clinical trials in support of pharmaceutical and biotechnology companies'​ drug development projects around the globe.

* 360 bed phase I clinical capacity
* Bioanalytical lab
* Onsite organic synthesis lab
* Biorepository services
* Clinical data management
* Medical writing
* PK / Biostatistics
* Clinical trial monitoring

In addition to FIH, BA/BE, and PK/DDI studies, we have specialized skills in respiratory, transdermal delivery systems (including SIS studies), and patient PK studies.

Our reputation is built upon principles of on-time performance, responsiveness to the industry we serve, and delivery of uncompromising quality at reasonable costs.

Our client-focused approach truly differentiates us from other contract research organizations. Pharma Medica Research has developed processes that put the needs of our clients first. These include flexible study scheduling, rapid preliminary results turnaround and prompt final report delivery. Outsourcing should not be complicated. We are there to make your project implementation as simple as possible.

We are a global healthcare intelligence partner, consistently ranked among the top CROs and best employers worldwide.
We help develop life-saving and life-improving drugs with our comprehensive clinical development services, including data management, statistical analysis, clinical trial management, medical writing, and regulatory and drug development consulting.

Apath is a privately held technology licensing company engaged in the commercial application of virology and viral genetics to assist pharmaceutical companies in discovering and developing therapeutic products for the treatment of viral infections. The current focus of Apath is on hepatitis C virus (HCV). The company also works with other RNA viruses that are human pathogens, including Influenza, Respiratory Syncytial Virus (RSV) and Hemorrhagic Fever Viruses.

CH Technologies is a partner to the scientific community, to create the innovative tools capable of supporting the advancement of inhalation toxicology research. We stand ready to offer complete solutions that harness our devotion to the sciences and our openness to re-engineering our product concepts to perfectly suit the needs of scientists working to expand the boundary of man's knowledge.

In the field of toxicology, whether inhalation, respiratory or test atmosphere generation for in-vivo and in-vitro research, the microscopic properties of particles (respirable or non-respirable), far exceed the power of our perception. Despite their small size, the impacts that they have on our lives and global environment are profound. Combining the latest technology with our established expertise in aerosol science, we work beyond the current capabilities of research to push the boundaries of particle, gas and vapor toxicology.

This is why here at CH Technologies, we believe the small things count. Our attention to detail has long been a mark of quality on our products, resulting not only in publications, but lasting relationships with our customers.